| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $29.5M | -37.7% |
| SG&A Expense | $13.3M | -13.3% |
| Operating Income | -$42.8M | +31.7% |
| Interest Expense | $2.1M | +22.3% |
| Income Tax | $0 | — |
| Net Income | -$37.5M | +39.5% |
| EPS (Basic) | -$0.64 | +39.6% |
| EPS (Diluted) | -$0.64 | +39.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $144.4M | +0.0% |
| Short-term Investments | $29.9M | +0.0% |
| Current Assets | $147.8M | -18.3% |
| Total Assets | $148.3M | -18.2% |
| Current Liabilities | $22.3M | +44.9% |
| Long-term Debt | $15.3M | -6.4% |
| Total Liabilities | $28.5M | -5.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.3M | +46.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $30.0M | +200.2% |
| Financing Cash Flow | -$1.3M | -204.1% |
| Free Cash Flow | -$30.3M | +46.5% |
| Stockholders' Equity |
| $119.8M |
| -20.7% |